Literature DB >> 32212047

Elevated body mass index facilitates early postoperative complications after surgery for intracranial meningioma.

Matthias Schneider1, Valeri Borger2, Daniel Grigutsch3, Ági Güresir2, Anna-Laura Potthoff2, Markus Velten3, Hartmut Vatter2, Erdem Güresir2, Patrick Schuss2.   

Abstract

Surgical resection represents the primary treatment option for patients suffering from intracranial meningioma. However, early postoperative complications significantly worsen initial favorable postoperative outcomes. Therefore, the ability to preoperatively assess potential risk factors for early postoperative unfavorable events is important to preselect critical patients who might require special attention during clinical management. In the current study, we therefore analyzed our institutional database in order to identify risk factors associated with early postoperative complications after initial meningioma resection. Between 2014 and 2017, 202 patients with intracranial supratentorial meningioma were surgically treated at the authors' institution. Early postoperative complications were defined as any postoperative event requiring further surgical measures within 30 days following initial meningioma resection. A multivariate analysis was performed to identify independent risk factors associated with postoperative complications after surgical meningioma therapy. Overall, 13 out of 202 meningioma patients developed early postoperative complications (6%). The multivariate analysis revealed obesity in terms of elevated body mass index (BMI ≥ 30 kg/m2) (p = 0.03), the presence of atrial fibrillation (p = 0.001) as well as the preoperative Karnofsky Performance Status Scale < 70% (p = 0.004) as independent predictors for early postoperative complications in the course of supratentorial meningioma resection. Obesity is associated with a higher risk of postoperative unfavorable events that require further surgical treatment. Furthermore, the present study identifies several additional risk factors for the development of early postoperative complications after intracranial meningioma resection enabling to preoperatively select for high-risk patients that might require special attention in clinical and surgical management.

Entities:  

Keywords:  Body mass index; Cranial surgery; Meningioma; Postoperative complications

Year:  2020        PMID: 32212047     DOI: 10.1007/s10143-020-01281-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  24 in total

1.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordonna Fulop; Max Liu; Rachel Blanda; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-10-27       Impact factor: 12.300

Review 2.  Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.

Authors:  R Sawaya; M Hammoud; D Schoppa; K R Hess; S Z Wu; W M Shi; D M Wildrick
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

3.  Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery.

Authors:  Balachundhar Subramaniam; Adam Lerner; Victor Novack; Kamal Khabbaz; Maya Paryente-Wiesmann; Philip Hess; Daniel Talmor
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

4.  Predictive factors of complications post intracranial meningioma surgery leading to early unplanned reoperations - a single center study.

Authors:  Borys M Kwinta; Roger M Krzyżewski; Kornelia M Kliś; Marcin R Dragan; Paulina Donicz; Małgorzata Gackowska; Krzysztof Stachura; Marek Moskała
Journal:  Folia Med Cracov       Date:  2018

5.  Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery.

Authors:  Anna Frisch; Prakash Chandra; Dawn Smiley; Limin Peng; Monica Rizzo; Chelsea Gatcliffe; Megan Hudson; Jose Mendoza; Rachel Johnson; Erica Lin; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2010-04-30       Impact factor: 19.112

Review 6.  Meningiomas.

Authors:  Ian R Whittle; Colin Smith; Parthiban Navoo; Donald Collie
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

7.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  A B Adegbite; M I Khan; K W Paine; L K Tan
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

8.  Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011.

Authors:  John D Rolston; Seunggu J Han; Catherine Y Lau; Mitchel S Berger; Andrew T Parsa
Journal:  J Neurosurg       Date:  2013-11-22       Impact factor: 5.115

9.  Multivariate risk factor analysis and literature review of postoperative deterioration in Karnofsky Performance Scale score in elderly patients with skull base meningioma.

Authors:  Manish Kolakshyapati; Fusao Ikawa; Masaru Abiko; Takafumi Mitsuhara; Yasuyuki Kinoshita; Masaaki Takeda; Kaoru Kurisu
Journal:  Neurosurg Focus       Date:  2018-04       Impact factor: 4.047

10.  Prognostic factors of microsurgical treatment of intracranial meningiomas - A multivariate analysis.

Authors:  Maika Kreßner; Felix Arlt; Wolf Riepl; Jürgen Meixensberger
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

View more
  1 in total

1.  Benchmarking Safety Indicators of Surgical Treatment of Brain Metastases Combined with Intraoperative Radiotherapy: Results of Prospective Observational Study with Comparative Matched-Pair Analysis.

Authors:  Motaz Hamed; Anna-Laura Potthoff; Julian P Layer; David Koch; Valeri Borger; Muriel Heimann; Davide Scafa; Gustavo R Sarria; Jasmin A Holz; Frederic Carsten Schmeel; Alexander Radbruch; Erdem Güresir; Niklas Schäfer; Patrick Schuss; Stephan Garbe; Frank A Giordano; Ulrich Herrlinger; Hartmut Vatter; Leonard Christopher Schmeel; Matthias Schneider
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.